MBDCap-Seq/MethylCap-Seq/MBD-Seq/MBDCap/MiGS

MBDCap-Seq/MethylCap-Seq/MBD-Seq/MBDCap/MiGS

Methyl-CpG binding domain-based capture and sequencing (MethylCap , MBD-Seq , MBDCap-Seq , MBDCap) or MBD-isolated genome sequencing (MiGS ), uses proteins to capture methylated DNA in the genome. Genomic DNA is first sonicated and incubated with tagged MBD proteins that can bind methylated cytosines. The protein-DNA complex is then precipitated with antibody-conjugated beads that are specific to the protein tag. Deep sequencing provides greater genome coverage, representing the majority of MBD-bound methylated DNA.

Pros:
  • Genome-wide coverage of 5mC in dense CpG areas and repeat regions
  • MBD proteins do not interact with 5hmC
Cons:
  • Genome-wide CpGs and non-CpG methylation is not covered
  • Areas with less dense 5mC are also missed
  • Base-pair resolution is lower (~150 bp) as opposed to single base resolution
  • Protein-based selection is biased towards hypermethylated regions